| 221/318 | US=23 / Clín/Médica Costa MC. Definição, aspectos clínicos e compreensão dos aspectos moleculares que levam ao acometimento de diversos sistemas: insuficiência renal. In: Silva FP, Velasco IT. Sepse. Barueri: Manole, 2007. p. 64-74. ISBN 85-2042558-5. INSUFICIENCIA RENAL; SEPSE; FATORES HEMODINAMICOS; FATORES NAO-HEMODINAMICOS; ALTERACOES TUBULARES; LESAO ENDOTELIAL; APOPTOSE |
| 222/318 | US=23 / Clín/Médica Bilate AMB, Neto EC. Aspectos imunológicos: reconhecimento e ataque ao antígeno: linfócitos T. In: Silva FP, Velasco IT. Sepse. Barueri: Manole, 2007. p. 250-7. ISBN 85-2042558-5. |
| 223/318 | US=23 / Clín/Médica Azevedo LCP. Imunodepressão em sepse: apoptose. In: Silva FP, Velasco IT. Sepse. Barueri: Manole, 2007. p. 389-9. ISBN 85-2042558-5. |
| 224/318 | US=35 / Câncer Paker JE. Molecular foundations of AML pathogenesis and physiology: myelodysplasia-related AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 43-70. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; MIELODISPLASIA; SINDROMES MIELODISPLASICAS; LEUCEMOGENESE; APOPTOSE; PROLIFERACAO; CICLO CELULAR |
| 225/318 | US=35 / Câncer Mesa RA, Kaufmann SH. Molecular foundations of AML pathogenesis and physiology: altered apoptosis in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 133-61. ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; APOPTOSE; RESISTENCIA MEDICAMENTOSA; BCL-2; MCL-1; XIAP; MICROAMBIENTE DA MEDULA OSSEA; RAS; FLT3 |
| 226/318 | US=46 / Câncer Bronchud MH. Molecular oncology. In: Meyers RA. Cancer: from mechanisms to therapeutic approaches. New Jersey: Wiley-Blackwell, 2007. p. 3-54. ISBN 978-3-527-31768-4. ONCOLOGIA MOLECULAR; ANGIOGENESE; APOPTOSE; ESTADO BINARIO; CARCINOGENESE; ADESAO CELULAR; CHECKPOINTS DO CICLO CELULAR; RESISTENCIA AS DROGAS; FACTORES DE CRESCIMENTO; NEOPLASIA INTRA-EPITELIAL; ONCOGENESES; MUTACOES; PROTEASOMES; CELULAS ESTROMAIS E CANCRO; GENES SUPRESSORES DE TUMORES; ANTIGENIOS TUMORAIS |
| 227/318 | US=46 / Câncer Brown VD, Gallie BL. Molecular genetics of retinoblastoma. In: Meyers RA. Cancer: from mechanisms to therapeutic approaches. New Jersey: Wiley-Blackwell, 2007. p. 311-37. ISBN 978-3-527-31768-4. GENETICA MOLECULAR DO RETINOBLASTOMA; APOPTOSE; E2F; LOH; PROBAND; RB1; RETINOBLASTOMA; SV40; TAG; SUPRESSOR TUMORAL |
| 228/318 | US=49 / Câncer Krammer PH, Kaminski M, KieBling M. No life without death. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 111-38. ISBN 978-0-12-006697-1. VIDA; MORTE; VIDA SEM MORTE; APOPTOSE NA VIDA; APOPTOSE NA DOENCA; HIV |
| 229/318 | US=77-J / Câncer Araújo Júnior RF, Moraes GM, Otake AH. Apoptose e outras formas de morte celular. In: Lopes A, Chammas R, Iyeyasu H. Oncologia para a graduação. 3ª ed. São Paulo: Lemar, 2013. p. 105-11. ISBN 8-5866523-7-0. CANCER; APOPTOSE; MORTE CELULAR; AUTOFAGIA; NECROSE; MITOSE CATASTROFICA |
| 230/318 | US=57-B / Biol/Mol Weinberg RA. p53 and apoptosis: master guardian and executioner. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 307-56. ISBN 0-8153-4078-8. P53; APOPTOSE; PAPOVAVIRUS; MUTANTES DE P53; NATUREZA DAS MUTACOES DO GENE P53; DANO AO DNA; GENOTIPO P53; RESPOSTAS CELULARES A RADIACAO; ACUMULACAO DE P53; CELULAS P53 MUTANTES |
| 231/318 | US=58 / Biol/Mol Blankenberg FG, Strauss HW. Imaging of apoptosis. In: Shields AF, Price P. In vivo imaging of cancer therapy. New Jersey: Humana Press, 2007. p. 303-16. (Cancer Drug Discovery and Development) ISBN 978-1-58829-633-7. IMAGEM DE APOPTOSE; LIPIDO PROTAO DE RESSONANCIA MAGNETICA; ESPECTROSCOPIA; AGENTES DE CONTRASTE PARA RESSONANCIA; CINTILOGRAFIA DE APOPTOSE |
| 232/318 | US=68 / Biol/Mol Chang KCN, Komm B, Arnold NB, Korc M. The application of differential display as a gene profiling tool. In: Fisher PB. Cancer genomics and proteomics: methods and protocols. New Jersey: Humana Press, 2007. p. 31-40. (Methods in Molecular Biology, 383) ISBN 978-1-58829-504-0. EXIBICAO DIFERENCIAL; EXPRESSAO DO GENE; RT-PCR; CANCER DE PANCREAS; TIOREDOXINA; APOPTOSE |
| 233/318 | US=7 / Patologia King TC. Lesão celular, resposta celular à lesão e morte celular. In: ___. Patologia. Rio de Janeiro: Elsevier, 2007. p. 1-20. (Série Elsevier de Formação Básica Integrada) ISBN 85-3522349-1. MECANISMOS DE LESAO CELULAR; HIPOXIA; ISQUEMIA; LESAO ISQUEMICA; LESAO INDUZIDA POR RADICAIS LIVRES; LESAO INFLAMATORIA; LESAO INFECCIOSA; LESAO FISICA; LESAO QUIMICA; LESAO NUTRICIONAL; LESAO GENETICA; ENVELHECIMENTO CELULAR; RESPOSTA CELULAR; HIPERPLASIA; HIPERTROFIA; ATROFIA; METAPLASIA; DISPLASIA; APOPTOSE; NECROSE CELULAR |
| 234/318 | US=82 / Biol/Mol Schulz WA. Apoptosis and replicative senescence in cancer. In: ___. Molecular biology of human cancers: an advanced student's textbook. New York: Springer, 2007. p. 145-65. ISBN 978-1-4020-6559-0. CANCER; APOPTOSE; SENESCENCIA REPLICATIVA; PROLIFERACAO CELULAR |
| 235/318 | US=92 / Biol/Mol Kaufmann SH. Apoptosis and alternative modes of cell death: the intrinsic pathway of apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 3-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; CASPASES; CARCINOGENESE; BCL-2; AIP; RESISTENCIA AS DROGAS; DROGAS ANTICANCER |
| 236/318 | US=92 / Biol/Mol Ricci MS, El-Deiry WS. Apoptosis and alternative modes of cell death: the extrinsic pathway of apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 31-54. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; TNF; FAS; TRAIL; NF-KB; QUIMIOTERAPIA; RECEPTOR MORTE; RECEPTOR CHAMARIZ; VIA EXTRINSECA; AUTOIMUNIDADE |
| 237/318 | US=92 / Biol/Mol Wouters BG, Chiu RK. Apoptosis and alternative modes of cell death: evaluating the importance of apoptosis and other determinants of cell death and survival. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 55-72. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; CLONOGENICA SOBREVIVENCIA; SENESCENCIA; TERAPIA DO CANCER |
| 238/318 | US=92 / Biol/Mol Djavaheri-Mergny M, Botti J, Codogno P. Apoptosis and alternative modes of cell death: autophagy and autophagic cell death. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 93-107. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. AUTOFAGIA; APOPTOSE; MORTE CELULAR; CANCER; MACROAUTOPHAGY; LISOSSOMO; TRANSDUCAO DE SINAL |
| 239/318 | US=92 / Biol/Mol Allen GW, Harari PM. Resistance and sensitization: the advancement of epidermal growth factor receptor inhibitors in cancer therapy. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 335-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; RADIACAO; APOPTOSE; INIBIDORES DE MOLECULAS PEQUENAS; ANTICORPOS MONOCLONAIS |
| 240/318 | US=92 / Biol/Mol Houghton JA. Established cancer therapies: antimetabolites. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 361-82. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. ANTIMETABOLITES; MORTE CELULAR; APOPTOSE; CATASTROFE MITOTICA; NECRESIS; SENESCENCIA |